GBS (GBS) Competitors $1.14 -0.03 (-2.56%) As of 10/6/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock GBS vs. TMDIF, PETV, HSAQ, RVP, CTCX, BTCY, IVF, DYNT, TTOO, and IONMShould you be buying GBS stock or one of its competitors? The main competitors of GBS include Titan Medical (TMDIF), PetVivo (PETV), Health Sciences Acquisitions Co. 2 (HSAQ), Retractable Technologies (RVP), Carmell (CTCX), Biotricity (BTCY), INVO Fertility (IVF), Dynatronics (DYNT), T2 Biosystems (TTOO), and Assure (IONM). These companies are all part of the "surgical & medical instruments" industry. GBS vs. Its Competitors Titan Medical PetVivo Health Sciences Acquisitions Co. 2 Retractable Technologies Carmell Biotricity INVO Fertility Dynatronics T2 Biosystems Assure GBS (NYSE:GBS) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings. Is GBS or TMDIF more profitable? Titan Medical's return on equity of -82.31% beat GBS's return on equity.Company Net Margins Return on Equity Return on Assets GBSN/A -85.64% -54.42% Titan Medical N/A -82.31%-51.47% Do institutionals & insiders hold more shares of GBS or TMDIF? 2.8% of GBS shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 0.3% of GBS shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, GBS or TMDIF? GBS has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Does the media favor GBS or TMDIF? In the previous week, GBS had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for GBS and 0 mentions for Titan Medical. GBS's average media sentiment score of 0.22 beat Titan Medical's score of 0.00 indicating that GBS is being referred to more favorably in the media. Company Overall Sentiment GBS Neutral Titan Medical Neutral Which has better valuation & earnings, GBS or TMDIF? Titan Medical has higher revenue and earnings than GBS. GBS is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGBSN/AN/A-$8.31M-$0.56-2.04Titan Medical$17.63M3.11$6.95M$0.059.60 SummaryTitan Medical beats GBS on 6 of the 11 factors compared between the two stocks. Get GBS News Delivered to You Automatically Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBS vs. The Competition Export to ExcelMetricGBSSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$16.98M$68.45M$6.11B$21.96BDividend YieldN/AN/A5.51%3.56%P/E Ratio-2.0410.8885.6929.67Price / SalesN/A39.30583.0197.97Price / CashN/A18.4126.3018.33Price / Book2.5914.6113.244.61Net Income-$8.31M-$26.69M$3.30B$1.01B7 Day PerformanceN/A2.03%4.64%0.13%1 Month Performance-26.45%0.59%8.36%2.32%1 Year Performance-28.30%65.64%87.97%13.84% GBS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBSGBSN/A$1.14-2.6%N/A-26.4%$16.98MN/A-2.047TMDIFTitan MedicalN/A$0.44-1.4%N/A+1,226.1%$50.60M$17.63M-0.3550PETVPetVivoN/A$1.10+6.8%N/A+127.5%$30.12M$1.05M-2.4420News CoverageGap DownHSAQHealth Sciences Acquisitions Co. 2N/A$2.46+1.7%N/A-45.6%$27.58MN/A0.004RVPRetractable Technologies1.5179 of 5 stars$0.84+2.7%N/A+19.8%$24.55M$38.16M-1.56240Gap DownCTCXCarmellN/A$0.74flatN/A+110.1%$15.47M$32.84K0.0014BTCYBiotricityN/A$0.53-1.9%N/A+62.0%$14.43M$12.06M-0.4940IVFINVO Fertility0.1714 of 5 stars$0.76-7.2%N/A-96.8%$3.57M$6.62M-0.0110DYNTDynatronicsN/A$0.07-7.1%N/A-51.1%$857K$33.60M-0.08200Gap DownTTOOT2 BiosystemsN/A$0.01+0.8%N/A-99.4%$259K$7.68M0.00180IONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130 Related Companies and Tools Related Companies Titan Medical Alternatives PetVivo Alternatives Health Sciences Acquisitions Co. 2 Alternatives Retractable Technologies Alternatives Carmell Alternatives Biotricity Alternatives INVO Fertility Alternatives Dynatronics Alternatives T2 Biosystems Alternatives Assure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GBS) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
